Farci P, Niro GA (2012) Clinical features of hepatitis D. Semin Liver Dis 32:228–236
Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ (2009) Identification of androgen
response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in
chronic hepatitis B. Hepatology 50:1392–1402
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender
disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science
317:121–124
Wang SH, Yeh SH, Lin WH, Yeh KH, Yuan Q, Xia NS, Chen DS, Chen PJ (2012) Estrogen
receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear
factor 4alpha. Gastroenterology 142:989–998. e984
Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD
(1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in
Shanghai, People’s Republic of China. Cancer Epidemiol Biomark Prev 3:3–10
Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen
CJ, Taiwan Community-Based Cancer Screening Project G (2002) Hepatitis B e antigen and
the risk of hepatocellular carcinoma. N Engl J Med 347:168–174
Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J,
Tang ZY (2007) Positive serum hepatitis B e antigen is associated with higher risk of early
recurrence and poorer survival in patients after curative resection of hepatitis B-related hepa-
tocellular carcinoma. J Hepatol 47:684–690
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, Group R-HS (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA
level. JAMA 295:65–73
Chen CJ, Yang HI, Iloeje UH, Group R-HS (2009) Hepatitis B virus DNA levels and outcomes
in chronic hepatitis B. Hepatology 49:S72–S84
Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, Lam Chan S, Yeo W, Sung JJ, Mok TS
(2008) High viral load and hepatitis B virus subgenotype ce are associated with increased risk
of hepatocellular carcinoma. J Clin Oncol 26:177–182
Lin CL, Kao JH (2011) The clinical implications of hepatitis B virus genotype: recent
advances. J Gastroenterol Hepatol 26(Suppl 1):123–130
Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical out-
comes in patients with chronic hepatitis B. Gastroenterology 118:554–559
Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ (2004) Genotype C
hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut
53:1494–1498
Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS, Chen
DS (2004) Clinical relevance of hepatitis B virus genotype in children with chronic infection
and hepatocellular carcinoma. Gastroenterology 127:1733–1738
Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J (2002) Influence of hepatitis B virus
genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology
123:1848–1856
Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P (2000) Molecular bases for the
development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin
Cancer Biol 10:211–231
Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y, Okanoue T (2005) Hepatitis
B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic
genetic change leading to hepatocarcinogenesis. Oncogene 24:4340–4348
Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot
P (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related
hepatocellular carcinomas. Gut 54:1162–1168
Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon
C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, Wang
G, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, Zhou W, Zhang C, Hardwick J, Buser
